Reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
For the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Prophylaxis of clinical manifestations of cytomegalovirus infection in patients subjected to immunosuppressive therapy, particularly in transplant recipients.
The concomitant use of adequate virostatic agents should be considered for CMV-prophylaxis.
Reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
For the paediatric population: Sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Severe forms of acne (such as nodular or conglobate acne or acne at risk of permanent scarring) resistant to adequate courses of standard therapy with systemic anti-bacterials and topical therapy.
Miglustat is indicated for the oral treatment of adult patients with mild to moderate type 1 Gaucher disease. Miglustat may be used only in the treatment of patients for whom enzyme replacement therapy is unsuitable.
Miglustat is indicated for the treatment of progressive neurological manifestations in adult patients and paediatric patients with Niemann-Pick type C disease.
Deferiprone monotherapy is indicated for the treatment of iron overload in patients with thalassaemia major when current chelation therapy is contraindicated or inadequate.
Deferiprone in combination with another chelator is indicated in patients with thalassaemia major when monotherapy with any iron chelator is ineffective, or when prevention or treatment of life-threatening consequences of iron overload (mainly cardiac overload) justifies rapid or intensive correction
Flatulence and indigestion associated with hyperchlorhydria.
- To render the urine alkaline in the treatment of inflammatory conditions of the urinary tract associated with acidic urine.
- In gout therapy, as an adjuvant with uricosuric agents.
- For prevention of crystalluria during treatment with sulfonamides.
Flatulence and indigestion associated with hyperchlorhydria.
- To render the urine alkaline in the treatment of inflammatory conditions of the urinary tract
associated with acidic urine.
- In gout therapy, as an adjuvant with uricosuric agents.
- For prevention of crystalluria during treatment with sulfonamides.
